Experimental models to identify antimetastatic drugs: are we there yet? A position paper.
Veterans Administration Medical Cancer, Northport, New York 11768, USA. zucker.stanley@northport.va.gov
S
S
Zucker
D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015195:Drug Design; D006801:Humans; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors*; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000473:pathology; D011480:Protease Inhibitors / Q000138:chemical synthesis* / Q000627:therapeutic use*; D019714:Tissue Inhibitor of Metalloproteinases / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011480:Protease Inhibitors; D019714:Tissue Inhibitor of Metalloproteinases; D008666:Metalloendopeptidases